InvestorsHub Logo
Followers 68
Posts 3510
Boards Moderated 0
Alias Born 01/23/2006

Re: leifsmith post# 23771

Monday, 11/23/2015 5:19:57 PM

Monday, November 23, 2015 5:19:57 PM

Post# of 30990
That is very good news:

2015-11-09 Patent: Anatabine for Autism Spectrum and Seizure Disorders

http://investors.rockcreekpharmaceuticals.com/2015-11-09-Rock-Creek-Pharmaceuticals-Announces-European-Patent

Quote:
Rock Creek Pharmaceuticals Announces European Patent Allowance for the Administration of Anatabine to Treat Autism Spectrum and Seizure Disorders and Third Quarter Results

SARASOTA, Fla., Nov. 9, 2015 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (OTCPK: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory conditions, announced today its third quarter results. The Company also disclosed the Notification of Intent to Grant by the European Patent Office of a European patent for the administration of Anatabine to treat autism spectrum and seizure disorders.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.